Warfarin-Aspirin Recurrent Stroke study (WARSS) Trial - Is Warfarin Really a Reasonable Therapeutic Alternative to Aspirin for Preventing Recurrent Noncardioembolic Ischemic Stroke

    Research output: Contribution to journalReview article

    42 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1723-1726
    JournalStroke
    Volume33
    DOIs
    Publication statusPublished - 2002

    Cite this